Literature DB >> 19865172

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.

Kendle M Maslowski1, Angelica T Vieira, Aylwin Ng, Jan Kranich, Frederic Sierro, Di Yu, Heidi C Schilter, Michael S Rolph, Fabienne Mackay, David Artis, Ramnik J Xavier, Mauro M Teixeira, Charles R Mackay.   

Abstract

The immune system responds to pathogens by a variety of pattern recognition molecules such as the Toll-like receptors (TLRs), which promote recognition of dangerous foreign pathogens. However, recent evidence indicates that normal intestinal microbiota might also positively influence immune responses, and protect against the development of inflammatory diseases. One of these elements may be short-chain fatty acids (SCFAs), which are produced by fermentation of dietary fibre by intestinal microbiota. A feature of human ulcerative colitis and other colitic diseases is a change in 'healthy' microbiota such as Bifidobacterium and Bacteriodes, and a concurrent reduction in SCFAs. Moreover, increased intake of fermentable dietary fibre, or SCFAs, seems to be clinically beneficial in the treatment of colitis. SCFAs bind the G-protein-coupled receptor 43 (GPR43, also known as FFAR2), and here we show that SCFA-GPR43 interactions profoundly affect inflammatory responses. Stimulation of GPR43 by SCFAs was necessary for the normal resolution of certain inflammatory responses, because GPR43-deficient (Gpr43(-/-)) mice showed exacerbated or unresolving inflammation in models of colitis, arthritis and asthma. This seemed to relate to increased production of inflammatory mediators by Gpr43(-/-) immune cells, and increased immune cell recruitment. Germ-free mice, which are devoid of bacteria and express little or no SCFAs, showed a similar dysregulation of certain inflammatory responses. GPR43 binding of SCFAs potentially provides a molecular link between diet, gastrointestinal bacterial metabolism, and immune and inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19865172      PMCID: PMC3256734          DOI: 10.1038/nature08530

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  29 in total

1.  The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids.

Authors:  Andrew J Brown; Susan M Goldsworthy; Ashley A Barnes; Michelle M Eilert; Lili Tcheang; Dion Daniels; Alison I Muir; Mark J Wigglesworth; Ian Kinghorn; Neil J Fraser; Nicholas B Pike; Jay C Strum; Klaudia M Steplewski; Paul R Murdock; Julie C Holder; Fiona H Marshall; Philip G Szekeres; Shelagh Wilson; Diane M Ignar; Steve M Foord; Alan Wise; Simon J Dowell
Journal:  J Biol Chem       Date:  2002-12-19       Impact factor: 5.157

2.  Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2.

Authors:  Taeweon Lee; Ralf Schwandner; Gayathri Swaminath; Jennifer Weiszmann; Mario Cardozo; Joanne Greenberg; Peter Jaeckel; Hongfei Ge; Yingcai Wang; Xianyun Jiao; Jiwen Liu; Frank Kayser; Hui Tian; Yang Li
Journal:  Mol Pharmacol       Date:  2008-09-25       Impact factor: 4.436

3.  Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease.

Authors:  J P Segain; D Raingeard de la Blétière; A Bourreille; V Leray; N Gervois; C Rosales; L Ferrier; C Bonnet; H M Blottière; J P Galmiche
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

4.  Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation.

Authors:  Emmanuel Le Poul; Cecile Loison; Sofie Struyf; Jean-Yves Springael; Vincent Lannoy; Marie-Eve Decobecq; Stephane Brezillon; Vincent Dupriez; Gilbert Vassart; Jo Van Damme; Marc Parmentier; Michel Detheux
Journal:  J Biol Chem       Date:  2003-04-23       Impact factor: 5.157

5.  Butyrate-enhanced TNFalpha-induced apoptosis is associated with inhibition of NF-kappaB.

Authors:  Hardi Lührs; Theodor Kudlich; Manfred Neumann; Jürgen Schauber; Ralph Melcher; Andrea Gostner; Wolfgang Scheppach; Thomas P Menzel
Journal:  Anticancer Res       Date:  2002 May-Jun       Impact factor: 2.480

6.  Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial.

Authors:  Osamu Kanauchi; Toshihiro Suga; Masahiro Tochihara; Toshifumi Hibi; Makoto Naganuma; Terasu Homma; Hitoshi Asakura; Hiroshi Nakano; Kazuya Takahama; Yoshihide Fujiyama; Akira Andoh; Takashi Shimoyama; Nobuyuki Hida; Ken Haruma; Hideki Koga; Keiichi Mitsuyama; Michio Sata; Masanobu Fukuda; Atsushi Kojima; Tadao Bamba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

7.  Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability.

Authors:  Takuya Suzuki; Shoko Yoshida; Hiroshi Hara
Journal:  Br J Nutr       Date:  2008-03-18       Impact factor: 3.718

Review 8.  Regulation of short-chain fatty acid production.

Authors:  Sandra Macfarlane; George T Macfarlane
Journal:  Proc Nutr Soc       Date:  2003-02       Impact factor: 6.297

Review 9.  The "Microflora Hypothesis" of allergic disease.

Authors:  Andrew Shreiner; Gary B Huffnagle; Mairi C Noverr
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

10.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

View more
  1025 in total

Review 1.  Contributions of the intestinal microbiome in lung immunity.

Authors:  Jeremy P McAleer; Jay K Kolls
Journal:  Eur J Immunol       Date:  2017-08-31       Impact factor: 5.532

2.  Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes.

Authors:  Patrick Veiga; Carey Ann Gallini; Chloé Beal; Monia Michaud; Mary L Delaney; Andrea DuBois; Artem Khlebnikov; Johan E T van Hylckama Vlieg; Shivesh Punit; Jonathan N Glickman; Andrew Onderdonk; Laurie H Glimcher; Wendy S Garrett
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 3.  Gut microbiome, obesity, and metabolic dysfunction.

Authors:  Herbert Tilg; Arthur Kaser
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

4.  Bifidobacteria can protect from enteropathogenic infection through production of acetate.

Authors:  Shinji Fukuda; Hidehiro Toh; Koji Hase; Kenshiro Oshima; Yumiko Nakanishi; Kazutoshi Yoshimura; Toru Tobe; Julie M Clarke; David L Topping; Tohru Suzuki; Todd D Taylor; Kikuji Itoh; Jun Kikuchi; Hidetoshi Morita; Masahira Hattori; Hiroshi Ohno
Journal:  Nature       Date:  2011-01-27       Impact factor: 49.962

5.  Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41).

Authors:  Ikuo Kimura; Daisuke Inoue; Takeshi Maeda; Takafumi Hara; Atsuhiko Ichimura; Satoshi Miyauchi; Makio Kobayashi; Akira Hirasawa; Gozoh Tsujimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

Review 6.  The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer.

Authors:  Melissa M Kaczmarczyk; Michael J Miller; Gregory G Freund
Journal:  Metabolism       Date:  2012-03-07       Impact factor: 8.694

Review 7.  Mechanisms of inflammatory responses in obese adipose tissue.

Authors:  Shengyi Sun; Yewei Ji; Sander Kersten; Ling Qi
Journal:  Annu Rev Nutr       Date:  2012-03-09       Impact factor: 11.848

8.  VEGF-C mediated enhancement of lymphatic drainage reduces intestinal inflammation by regulating IL-9/IL-17 balance and improving gut microbiota in experimental chronic colitis.

Authors:  Xiaolei Wang; Jin Zhao; Li Qin
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 9.  The microbiome and regulation of mucosal immunity.

Authors:  Andrew J McDermott; Gary B Huffnagle
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

10.  Alterations of Cholesterol Metabolism in Inflammation-Induced Atherogenesis.

Authors:  David P Hajjar; Katherine A Hajjar
Journal:  J Enzymol Metab       Date:  2016-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.